Related Experiment Video
Updated: Aug 7, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Renal function after pediatric cardiac transplantation: the effect of early cyclosporin dosage
T S Hornung1, C G de Goede, C O'Brien
1Department of Paediatric Cardiology, Freeman Hospital, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom. tim.hornung@uhn.on.ca
Insights
Pediatric heart transplant recipients receiving high early cyclosporine A (CyA) doses experience persistent declines in renal function. This study highlights the critical impact of early immunosuppression on long-term kidney health in these young patients.
Area of Science:
- Pediatric Nephrology
- Cardiology
- Transplantation Medicine
Background:
- Limited data exists on long-term renal function in pediatric heart transplant recipients.
- High early doses of cyclosporine A (CyA) are commonly used to prevent rejection, potentially impacting kidney health.
Purpose of the Study:
- To document long-term renal function after pediatric heart transplantation.
- To assess the influence of early cyclosporine A (CyA) levels on renal function post-transplant.
Main Methods:
- Retrospective review of 54 pediatric heart transplant recipients surviving >6 months.
- Estimated glomerular filtration rate (GFR) calculated using the Schwartz formula at multiple time points post-transplant.
- Analysis of correlation between early trough CyA levels and changes in renal function.
Main Results:
- Mean GFR declined progressively from 72 mL/min/1.73 m(2) at 1 year to 57 mL/min/1.73 m(2) at 8 years post-transplant.
- Early post-transplant CyA levels (first 2 months) showed a correlation with the change in GFR during the first year (r(2) = 0.21).
Conclusions:
- Decline in renal function after pediatric heart transplantation is linked to early cyclosporine A exposure.
- This renal dysfunction persists even with subsequent reductions in CyA dosage, emphasizing the long-term consequences of initial immunosuppression levels.
Background:
There is little data on renal function in pediatric heart transplant recipients. Early rejection is a major concern and most units run high cyclosporin A (CyA) levels during the 2 to 3 months after transplantation. We sought to document long-term renal function after transplantation and to assess influence of early CyA levels.
Methods:
We reviewed all of our pediatric transplants between June 1985 and August 1998 who survived longer than 6 months (n = 54). Glomerular filtration rate (GFR) was estimated at 1, 2, 4, and 8 years posttransplantation using the Schwartz formula: GFR (mL/min/1.73m(2)) = [Ht(cm)/creatinine(micromol/L)] x X We also analyzed whether change in renal function correlated with trough CyA levels.
Results:
Median age at transplant was 4 years and median follow-up was 5 years. Survival rates were 87% at 1 year and 80% at 5 years. Mean GFR pretransplant was 79 +/- 19 mL/min/1.73 m(2), reflecting prerenal impairment. One year later, mean GFR was 72 mL/min/1.73 m(2); after 2 years it was 65 mL/min/1.73 m(2), after 4 years (n = 35) it was 60 mL/min/1.73 m(2), and after 8 years (n = 14) it was 57 mL/min/1.73 m(2). CyA levels during the first 2 months correlated with the change in GFR during the first year (r(2) = 0.21).
Conclusions:
This study demonstrates for the first time that decline in renal function after heart transplantation correlates with early CyA exposure; this dysfunction persists even when CyA doses are subsequently reduced.
Related Concept Videos
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management

